144 related articles for article (PubMed ID: 6318232)
1. Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine.
Thoolen MJ; Van Meel JC; Wilffert B; Timmermans PB; van Zwieten PA
Pharmacology; 1983; 27(5):245-54. PubMed ID: 6318232
[TBL] [Abstract][Full Text] [Related]
2. N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.
Arrigoni-Martelli E; Nielsen CK; Olsen UB; Petersen HJ
Experientia; 1980 Apr; 36(4):445-7. PubMed ID: 7379920
[TBL] [Abstract][Full Text] [Related]
3. Effects of an antihypertensive vasodilator, pinacidil, on regional blood flow in conscious spontaneously hypertensive rats.
Kimura S; Fujioka S; Fukui K; Tamaki T; Iwao H; Abe Y
J Pharmacobiodyn; 1988 Jun; 11(6):430-7. PubMed ID: 3171884
[TBL] [Abstract][Full Text] [Related]
4. Pinacidil-induced vascular relaxation: comparison to other vasodilators and to classical mechanisms of vasodilation.
Cohen ML; Kurz KD
J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S5-9. PubMed ID: 2466179
[TBL] [Abstract][Full Text] [Related]
5. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
Kawashima S; Liang CS
J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
[TBL] [Abstract][Full Text] [Related]
6. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
Shibamura S; Chiba T; Suzuki I; Akashi A
Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
[TBL] [Abstract][Full Text] [Related]
7. Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
Matsui K; Ogawa Y; Imai S
Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):124-33. PubMed ID: 2948465
[TBL] [Abstract][Full Text] [Related]
8. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
Carlsen JE; Kardel T; Hilden T; Tangø M; Trap-Jensen J
Clin Physiol; 1981 Aug; 1(4):375-84. PubMed ID: 7199409
[TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
[TBL] [Abstract][Full Text] [Related]
10. Effects of pinacidil on renal hemodynamics and function in anesthetized dogs.
Morimoto S; Sasaki Y; Matsumura Y
J Pharmacobiodyn; 1986 Feb; 9(2):146-55. PubMed ID: 3519923
[TBL] [Abstract][Full Text] [Related]
11. Effect of a new vasodilator, pinacidil (P 1134), on potassium, noradrenaline and serotonin induced contractions in rabbit vascular tissues.
Nielsen CK; Arrigoni-Martelli E
Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):427-31. PubMed ID: 7345884
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat.
Struyker-Boudier HA; van Essen H; Smits JF
Eur J Pharmacol; 1983 Nov; 95(3-4):151-9. PubMed ID: 6653667
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of the selectivity of 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3, 4-tetrahydronaphthalene (M-7) as an agonist of postjunctional alpha-2 adrenoceptors in the pithed normotensive rat.
Timmermans PB; Wilffert B; Davidesko D; Mathy MJ; Dijkstra D; Horn AS; van Zwieten PA
J Pharmacol Exp Ther; 1983 May; 225(2):407-9. PubMed ID: 6132992
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological studies on pinacidil, a new antihypertensive agent. (3). Studies on the vasodilating effects in isolated monkey arteries and the peripheral hypotensive mechanism in SHR].
Nakajima S; Ueda M
Nihon Yakurigaku Zasshi; 1987 Jul; 90(1):13-21. PubMed ID: 3653800
[TBL] [Abstract][Full Text] [Related]
15. Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine.
Kauffman RF; Schenck KW; Conery BG; Cohen ML
J Cardiovasc Pharmacol; 1986; 8(6):1195-200. PubMed ID: 2434746
[TBL] [Abstract][Full Text] [Related]
16. Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.
Waite RP; Lim SL; Pang CC
Br J Pharmacol; 1995 Oct; 116(4):2322-6. PubMed ID: 8564267
[TBL] [Abstract][Full Text] [Related]
17. Indications for vascular alpha- and beta-2 adrenoceptors in synapses of the muscarinic pathway in the pithed normotensive rat.
Wilffert B; Gouw MA; De Jonge A; Timmermans PB; van Zwieten PA
J Pharmacol Exp Ther; 1982 Oct; 223(1):219-23. PubMed ID: 6288920
[TBL] [Abstract][Full Text] [Related]
18. The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats.
Yoshioka M; Minami M; Saito H
Clin Exp Hypertens A; 1991; 13(5):1107-14. PubMed ID: 1773498
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, controlled trial comparing pinacidil to hydralazine in essential hypertension.
Byyny RL; Nies AS; LoVerde ME; Mitchell WD
Clin Pharmacol Ther; 1987 Jul; 42(1):50-7. PubMed ID: 3297468
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
